EcoR1 Capital’s Ventyx Biosciences VTYX Stock Holding History

EcoR1 Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$13.1M	–	68
2022 Q4	$13.1M	Hold	400,000	–	–	0.4%	34
2022 Q3	$14M	Sell	400,000 -900,000	-69%	-$19.9M	0.41%	32
2022 Q2	$15.9M	Hold	1,300,000	–	–	0.55%	31
2022 Q1	$17.6M	Hold	1,300,000	–	–	0.55%	35
2021 Q4	$25.8M	Buy	+1,300,000	New	+$24.6M	0.82%	25

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

EcoR1 Capital's VTYX Position: Q1 2023 in Review

EcoR1 Capital sold out of Ventyx Biosciences (VTYX) in Q1 2023, closing a stake of 400,000 shares — an estimated $13.1M sold.

EcoR1 Capital first reported a position in VTYX in Q4 2021 and held it in 5 quarters. The position peaked at $25.8M in Q4 2021. 146 funds tracked by Wall St. Rank hold VTYX as of Q1 2023.

EcoR1 Capital reported no remaining Ventyx Biosciences position as of Q1 2023 after selling out during the quarter.
EcoR1 Capital sold 400,000 Ventyx Biosciences shares in Q1 2023, an estimated $13.1M.
EcoR1 Capital first reported a position in Ventyx Biosciences in Q4 2021 and held it in 5 quarters.
EcoR1 Capital's Ventyx Biosciences position peaked at $25.8M in Q4 2021.
146 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2023.

Based on EcoR1 Capital's 13F filing for Q1 2023, filed 15 May 2023.